Sigma Healthcare Limited
SIG
Hisse Senetlerindeki Sıralama
#1035
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Hisse Fiyatı
$1.98
Piyasa Değeri
$22.76B
Değişim (1 gün)
-1.75%
Değişim (1 yıl)
0.45%
Ülke
AU
Ticaret Sigma Healthcare Limited (SIG)
Kategori
Healthcare
Sigma Healthcare Limited (SIG) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 9.21%
Sigma Healthcare Limited şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 9.21%'dir. 2024 yılı sonunda şirketin faaliyet marjı -2.17% idi.
Sigma Healthcare Limited için 2001 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 9.21% | -4,485.71% |
| 2025 | -0.21% | -90.32% |
| 2024 | -2.17% | 15.43% |
| 2023 | -1.88% | -41.25% |
| 2022 | -3.20% | 10.73% |
| 2021 | -2.89% | -7.07% |
| 2020 | -3.11% | -299.36% |
| 2019 | 1.56% | -23.53% |
| 2018 | 2.04% | -11.69% |
| 2017 | 2.31% | -9.06% |
| 2016 | 2.54% | 2.01% |
| 2015 | 2.49% | 5.51% |
| 2014 | 2.36% | 145.83% |
| 2013 | 0.96% | -45.76% |
| 2012 | 1.77% | 227.78% |
| 2011 | 0.54% | -77.22% |
| 2010 | 2.37% | -61.15% |
| 2009 | 6.10% | 13.38% |
| 2008 | 5.38% | -6.92% |
| 2007 | 5.78% | 21.43% |
| 2006 | 4.76% | -43.47% |
| 2004 | 8.42% | 22.38% |
| 2003 | 6.88% | 31.30% |
| 2002 | 5.24% | -5.59% |
| 2001 | 5.55% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 1.62% | -99.82% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.89% |
US
|
|
| 0.00% | - |
US
|
|
| 5.69% | -99.38% |
US
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.